Literature DB >> 19027641

Adolescent vaccination: coverage achieved by ages 13-15 years, and vaccinations received as recommended during ages 11-12 years, National Health Interview Survey 1997-2003.

Mary Mason McCauley1, Shannon Stokley, John Stevenson, Daniel B Fishbein.   

Abstract

PURPOSE: To present progress toward Healthy People 2010 vaccination objectives for adolescents aged 13-15 years, and to determine how much catch-up and routine vaccination was administered at the recommended ages of 11-12 years.
METHODS: Data from the 1997-2003 National Health Interview Survey were evaluated. In the first analysis, vaccination coverage levels for adolescents aged 13-15 years were determined for each survey year. Main outcome measures include the percent of adolescents who had received the three-dose hepatitis B vaccine (Hep B) series, the two-dose measles/mumps/rubella vaccine (MMR) series, the tetanus and diphtheria toxoids (Td) booster, and one dose of varicella vaccine. In the second analysis, data from all survey years were combined and vaccination dates were analyzed to determine the percentage of adolescents who were missing any vaccines at ages 11-12 and received them at that age. Data for varicella vaccine were sufficient only for the first analysis.
RESULTS: Among the approximately 15%-20% of respondents who reported vaccination history from records in the home and who were reporting on a 13-15-year-old, coverage with three doses of Hep B increased significantly during 1997-2001, from 15.2% to 55.0%. Coverage with MMR and Td fluctuated, with no significant increase; highs were 76.7% for MMR in 2003 and 36.2% for Td in 2002. Examination of vaccination dates for all surveyed adolescents showed that among 11-12-year-olds who needed catch-up vaccine, 0.6%-31.3% were brought up to date for Hep B and 22.1%-31.8% were brought up to date for MMR. For Td, 2.6%-15.4% of 11-12-year-olds who had not previously received Td received the vaccine.
CONCLUSION: Vaccination coverage among adolescents aged 13-15 years was below the Healthy People 2010 goals of 90%, but generally increased over the survey years. However, the suboptimal delivery of needed vaccines during ages 11 and 12 is concerning in light of recent vaccine recommendations targeted at this age. Continuing to focus on strategies to make adolescent preventive care, including vaccination, a new norm is essential.

Entities:  

Mesh:

Year:  2008        PMID: 19027641     DOI: 10.1016/j.jadohealth.2008.08.002

Source DB:  PubMed          Journal:  J Adolesc Health        ISSN: 1054-139X            Impact factor:   5.012


  6 in total

1.  Determining accurate vaccination coverage rates for adolescents: the National Immunization Survey-Teen 2006.

Authors:  Nidhi Jain; James A Singleton; Margrethe Montgomery; Benjamin Skalland
Journal:  Public Health Rep       Date:  2009 Sep-Oct       Impact factor: 2.792

Review 2.  Successes and challenges in varicella vaccine.

Authors:  Orestis Papaloukas; Georgia Giannouli; Vassiliki Papaevangelou
Journal:  Ther Adv Vaccines       Date:  2014-03

3.  Minor consent and delivery of adolescent vaccines.

Authors:  Carol A Ford; Martha P Skiles; Abigail English; Jianwen Cai; Robert P Agans; Shannon Stokley; Lauri Markowitz; Emilia H Koumans
Journal:  J Adolesc Health       Date:  2013-09-25       Impact factor: 5.012

4.  Examining future adolescent human papillomavirus vaccine uptake, with and without a school mandate.

Authors:  Amanda F Dempsey; David Mendez
Journal:  J Adolesc Health       Date:  2010-02-11       Impact factor: 5.012

5.  Attitudinal and demographic predictors of measles-mumps-rubella vaccine (MMR) uptake during the UK catch-up campaign 2008-09: cross-sectional survey.

Authors:  Katrina Brown; Graham Fraser; Mary Ramsay; Ruth Shanley; Noel Cowley; Johan van Wijgerden; Penelope Toff; Michelle Falconer; Michael Hudson; John Green; J Simon Kroll; Charles Vincent; Nick Sevdalis
Journal:  PLoS One       Date:  2011-05-13       Impact factor: 3.240

Review 6.  Varicella vaccination in Europe - taking the practical approach.

Authors:  Paolo Bonanni; Judith Breuer; Anne Gershon; Michael Gershon; Waleria Hryniewicz; Vana Papaevangelou; Bernard Rentier; Hans Rümke; Catherine Sadzot-Delvaux; Jacques Senterre; Catherine Weil-Olivier; Peter Wutzler
Journal:  BMC Med       Date:  2009-05-28       Impact factor: 8.775

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.